Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Primary Diagnosis of Major Depressive Disorder~* Hamilton Psychiatric Rating Scale for Depression-17-Item score of greater than or equal to 14 at baseline~Exclusion Criteria:~* Current psychoactive substance abuse or dependence, manic episode, or a lifetime diagnosis of bipolar or psychotic disorder~* Potentially violent to others or is at significant risk for suicide~* History or current evidence of gastrointestinal disease or history of surgery known to interfere with absorption or excretion~* Known presence of raised intraocular pressure or history of narrow angle glaucoma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Desvenlafaxine Succinate Sustained-Release Formulation 50 mg (Type: ACTIVE_COMPARATOR): None
- Desvenlafaxine Succinate Sustained-Release Formulation 25 mg (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).